The shingles vaccine is intended to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, also known as herpes zoster, but a new study suggests that it could have major secondary benefits.

Researchers at Case Western Reserve University have identified a potential link between the shingles vaccine and a reduced risk of developing vascular dementia.

The vaccine has also been associated with a significant decrease risk of cardiovascular events and death in people 50 and older.

Experts presented the findings last week at the Georgia World Congress Center in Atlanta, the site of IDWEEK 2025, a joint annual meeting of the leading infectious disease professional societies in the U.S.

The study authors examined health records from 174,000 adults in the U.

See Full Page